Eiger BioPharmaceuticals, Inc. (EIGR) Financials

Stock symbol EIGR is outdated, potentially delisted? Maybe it is available on other exchange?

EIGR Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2023	55.7 million	57.3 million
June 30, 2023	72.4 million	57.1 million
March 31, 2023	99.2 million	64.0 million
Dec. 31, 2022	120.1 million	64.8 million

EIGR Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2023	-14.6 million	1.0 million
June 30, 2023	-22.1 million	745000
March 31, 2023	-24.2 million	2.5 million
Dec. 31, 2022	-22.5 million	1.8 million

EIGR Net Income

No data available :(

EIGR Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2023	39.4 million	-	205000
June 30, 2023	53.6 million	40.3 million	322000
March 31, 2023	75.3 million	40.0 million	436000
Dec. 31, 2022	98.9 million	39.6 million	574000

EIGR Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2023	44.3 million
June 30, 2023	44.3 million
March 31, 2023	44.1 million
Dec. 31, 2022	44.1 million

EIGR Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2023	-	14.6 million	5.5 million	-
June 30, 2023	17000	19.4 million	5.5 million	-
March 31, 2023	216000	16.7 million	9.5 million	-
Dec. 31, 2022	224000	18.5 million	8.3 million	-

EIGR Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2023	3.2 million	115000
June 30, 2023	4.6 million	310000
March 31, 2023	4.1 million	118000
Dec. 31, 2022	2.7 million	345000

EIGR

Price: $1.72

52 week price:

1.10

43.35

Earnings Per Share: -58.50 USD

P/E Ratio: -0.10

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 759300

Ebitda: -8.8 million

Market Capitalization: 2.6 million

Links:

EIGR on Yahoo Finance